178 related articles for article (PubMed ID: 34815375)
1. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection.
Xu M; Cui C
Med Sci Monit; 2021 Nov; 27():e933109. PubMed ID: 34815375
[TBL] [Abstract][Full Text] [Related]
2. The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.
Lin Y; Jin H; Wu X; Jian Z; Zou X; Huang J; Guan R; Wei X
Aging (Albany NY); 2020 Jul; 12(14):14391-14405. PubMed ID: 32716315
[TBL] [Abstract][Full Text] [Related]
3. DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.
Zhang X; Hu Y; Pan Y; Xiong Y; Zhang Y; Han M; Dong K; Song J; Liang H; Ding Z; Zhang X; Zhu H; Liu Q; Lu X; Feng Y; Chen X; Zhang Z; Zhang B
Oncogene; 2022 Mar; 41(12):1821-1834. PubMed ID: 35140331
[TBL] [Abstract][Full Text] [Related]
4. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
Shen Q; Cicinnati VR; Zhang X; Iacob S; Weber F; Sotiropoulos GC; Radtke A; Lu M; Paul A; Gerken G; Beckebaum S
Mol Cancer; 2010 Aug; 9():227. PubMed ID: 20799954
[TBL] [Abstract][Full Text] [Related]
6. Involvement of discoidin domain 1 receptor in recurrence of hepatocellular carcinoma by genome-wide analysis.
Jian ZX; Sun J; Chen W; Jin HS; Zheng JH; Wu YL
Med Oncol; 2012 Dec; 29(5):3077-82. PubMed ID: 22752569
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
[TBL] [Abstract][Full Text] [Related]
8. Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.
Han SX; Wang JL; Guo XJ; He CC; Ying X; Ma JL; Zhang YY; Zhao Q; Zhu Q
J Immunol Res; 2014; 2014():262385. PubMed ID: 24860834
[TBL] [Abstract][Full Text] [Related]
9. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
11. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma.
Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P
J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135
[No Abstract] [Full Text] [Related]
13. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
14. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.
Liu WR; Tian MX; Tang Z; Fang Y; Zhou YF; Song SS; Jiang XF; Wang H; Tao CY; Zhou PY; Qu WF; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
Br J Cancer; 2020 Jul; 123(1):92-100. PubMed ID: 32376890
[TBL] [Abstract][Full Text] [Related]
15. Discoidin domain receptor 1 as a promising biomarker for high-grade gliomas.
Erdem D; Gunaldi M; Karaman I; Adilay U; Yılmaz İU; Eseoglu M; Avcıkurt A; Isıksacan N; Erdogan U; Gunaldi O
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147958
[TBL] [Abstract][Full Text] [Related]
16. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Discoidin Domain Receptor 1 Prevents Stroma-Induced Peritoneal Metastasis in Gastric Carcinoma.
Jin H; Ham IH; Oh HJ; Bae CA; Lee D; Kim YB; Son SY; Chwae YJ; Han SU; Brekken RA; Hur H
Mol Cancer Res; 2018 Oct; 16(10):1590-1600. PubMed ID: 29866925
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.
Ezzoukhry Z; Henriet E; Piquet L; Boyé K; Bioulac-Sage P; Balabaud C; Couchy G; Zucman-Rossi J; Moreau V; Saltel F
Eur J Cell Biol; 2016 Nov; 95(11):503-512. PubMed ID: 27720259
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
20. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study.
Dean DC; Feng W; Walker RL; Thanindratarn P; Temple HT; Trent JC; Rosenberg AE; Hornicek FJ; Duan Z
Clin Orthop Relat Res; 2023 Nov; 481(11):2140-2153. PubMed ID: 37768856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
